• About Lyratone

    Hearing technology's AI moment needed a foundation. We spent seven years building it.

    Founded in 2018, Lyratone Technologies specializes in the research and development of cutting-edge hearing health solutions. By integrating Software-Defined Hearing (SDH) and artificial intelligence with advanced acoustic technology, we're redefining the future of hearing aids — full-stack, for the B2B market.

  • Company Overview

    Lyratone focuses on the B2B market, providing enterprise customers with full-stack medical hearing aid and assistive hearing solutions — algorithms, integrated motherboards, complete devices, and fitting/tuning software. Our hearing aids are certified as Class II medical devices by the US FDA. Every product runs on the same self-developed Software-Defined Hearing architecture, and every partner chooses how much of that stack to own — from licensing the software alone to a full turnkey device.

    See the architecture →

    See how you can engage →

    Our vision

    Better hearing for better life.

    We believe better hearing changes lives — and that the fastest way to reach more of them is through partners, not just direct-to-consumer products. Lyratone exists to give hearing-technology brands a platform they can trust: reliable enough to build a business on, and advanced enough to keep them competitive as the category evolves.

  • Development history

    2018

    • Lyratone Technologies was founded.

    2019

    • Lyratone Hearing App launched (iOS/Android), combining hearing test and hearing-aid function — around 250,000 users to date.
    • First Software-Defined Hearing (SDH) -based hearing aid and embedded SoC R&D begins using Qualcomm 5124 chipset.

    2021

    • First commercial LyraOS embedded SDK ships, enabling a top-tier earbud brand to add hearing features to consumer electronics.

    2022

    • Major LyraOS upgrades for prescription air-conduction devices.

    2023

    • First full-device air-conduction hearing aid launches — US FDA OTC certified, 32-band WDRC on a 12nm chipset.

    2024

    • First bone-conduction hearing aid, developed with a strategic partner, with Lyratone supplying the LyraOS-embedded PCBA. Open-ear (OWS) development completed.

    2025

    • Continued focus on air-conduction, bone-conduction, and open-ear devices — all on a 12nm SDH architecture, versus the roughly 56nm typical of hardware-defined competitors. Multiple partner-collaboration hearing aids went to market.

    Where we are

    China

    Building 2-1F, No. 40 Beiyuan Road,

    Chaoyang District.

    Beijing, 100012

    China

    US

    750 Alma Ln, Suite 4601,

    Foster City,

    CA 94404,

    USA.